Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays
Idiosyncratic drug-induced liver injury (IDILI) is a significant source of drug recall and acute liver failure (ALF) in the United States. While current drug development processes emphasize general toxicity and drug metabolizing enzyme- (DME-) mediated toxicity, it has been challenging to develop co...
Main Authors: | Alexander D. Roth, Moo-Yeal Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2017/9176937 |
Similar Items
-
Idiosyncratic Drug-Induced Liver Injury (iDILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
by: Rolf Teschke, et al.
Published: (2021-03-01) -
IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY: DIAGNOSIS AND TREATMENT
by: S. I. Pimanov, et al.
Published: (2017-12-01) -
Discussion on idiosyncratic drug-induced liver injury in children
by: LU Yi, et al.
Published: (2015-08-01) -
Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges
by: Alison Jee, et al.
Published: (2021-03-01) -
Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports
by: Nelia Hernández, et al.
Published: (2014-03-01)